Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease
1 other identifier
observational
900
0 countries
N/A
Brief Summary
The study is an observational, cross-sectional study aimed at screening and accessing risk factors and complications for Chinese chronic kidney disease (CKD) patients. To investigate the prevalence of hypertension, cardiovascular and cerebrovascular diseases, protein energy malnutrition(PEM), cognitive impairment and other complications in the CKD patients. To develop biomarkers of CKD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2017
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2017
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedFirst Posted
Study publicly available on registry
August 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedAugust 11, 2017
August 1, 2017
9 months
June 13, 2017
August 8, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Prevalence of CKD complications
hypertension, cardiovascular and cerebrovascular diseases, protein energy malnutrition(PEM), cognitive impairment
baseline
Biomarkers of kidney function
baseline
Secondary Outcomes (6)
Genetic analyses
baseline
Questionnaire assessing cognitive function
baseline
Questionnaire assessing depression
baseline
Questionnaire assessing risk of malnutrition
baseline
Questionnaire assessing dietary intake
baseline
- +1 more secondary outcomes
Interventions
blood sample collection
Eligibility Criteria
subjects with 18 years or older
You may qualify if:
- age≥18 years
- clinical diagnosis of CKD
- signed informed consent
You may not qualify if:
- End-stage renal disease(ESRD) or dialysis
- Acute kidney injure(AKI)
- history of solid organ or bone marrow transplantation
- active malignancy within 24 months prior to screening or metastatic cancer
- HIV infection or AIDS
- acute inflammation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
serum, whole blood,urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
xiangmei chen
Chinese PLA General Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Academician of Chinese Academy of Engineering
Study Record Dates
First Submitted
June 13, 2017
First Posted
August 11, 2017
Study Start
August 1, 2017
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
August 11, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share